In this issue:
Interrupting endocrine therapy for pregnancy
Anthracycline or taxane chemotherapy for early-stage operable breast cancer
Extended aromatase inhibitors after endocrine therapy for postmenopausal breast cancer
Autologous fat transfer vs. implants for breast reconstruction
Allostatic load and all-cause mortality in breast cancer
Adherence to recommended lifestyle after treatment for high-risk breast cancer
Exemestane dose frequency for postmenopausal oestrogen receptor+ breast cancer
Long-term survival for breast cancer with brain metastases
RT or axillary surgery in sentinel node+ breast cancer
Endocrine therapy and cognitive decline in early breast cancer
Please login below to download this issue (PDF)